Number of the records: 1
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use
- 1.0559932 - ÚOCHB 2023 RIV eng P - Patent Document
Hocek, Michal - Tichý, Michal - Hajdúch, M. - Džubák, P.
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use.
2022. Owner: Ústav organické chemie a biochemie AV ČR, v. v. i. – Univerzita Palackého v Olomouci. Date of the patent acceptance: 10.08.2022. Patent Number: EP3478701
R&D Projects: GA TA ČR(CZ) TE01020028; GA ČR(CZ) GA16-00178S; GA MZd(CZ) NV15-31984A
Institutional support: RVO:61388963
Keywords : nucleosides * fused heterocycles * cytostatics
OECD category: Medicinal chemistry
https://worldwide.espacenet.com/patent/search/family/056550662/publication/EP3478701B1?q=EP3478701B1
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use The invention provides a new group of substituted thienopyrrolopyrimidine ribonucleosides of general formula I, wherein R is defined in the claims. The compounds of this invention show strong cytostatic and cytotoxic activities preferably against cancer cell lines of broad spectrum of diseases including tumors of various histogenetic origin.
Permanent Link: https://hdl.handle.net/11104/0333049
Number of the records: 1